Pertussis Vaccines: Whole-cell & Acellular Vaccines, Different Types & Manufacturers along with the Regimen in Various Age Groups

Respiratory Diseases

COVID19 pipeline advances as Novartis begins ph...

The U.S. FDA has given its nod to Seattle Genetics for its Tukysa (tucatinib) for advanced unresectable or metastatic HER2-positive breast cancer Genetics Tukysa (tucatinib) is a tyrosine kinase in...

Apr 21, 2020

copper against SARS-CoV-2
Novel coronavirus crumbles down as soon as it lands on copper

Research says copper disintegrates novel coronavirus – SARS-CoV-2- the moment it lands on the metal. The global coronavirus pandemic has made everyone around cautious of hygiene and cleanliness. The transmission of microbes through droplets, touching, sneezing has brought a wave face masks, 20-seconds hand wash,...

Find More
Ventilator demand amid Coronavirus crisis
Supply shortage: Why ventilators are in demand amid the Coronavirus crisis

The Novel Coronavirus since its outbreak in Wuhan China in November-2019 has infected around 1,848,439 people with 117,217 confirmed deaths in 213 countries, till date.  Countries around the world are working tirelessly to tackle the current situation. Local Governments in order to reduce the pace of corona...

Find More
covid-news
In the fight against COVID-19 – Lilly with Olumiant, Gilead with remdesivir, Rutgers with testing kit

Eli Lilly has announced to begin clinical trials of rheumatoid arthritis drug Olumiant to treat COVID-19 patients.  The company plans to explore the anti-inflammatory responses that were witnessed in rheumatoid arthritis patients, and how the drug – Olumiant – an oral JAK1/JAK2 inhibitor – might help in cur...

Find More

More Views & Analysis

Hydroxychloroquine and COVID-19
Is Hydroxychloroquine the answer to all the COVID-19 questions?

Amid the political debate, the US NIH has last week begun the clinical trials of the malarial drug hydroxychloroquine to test its efficacy and safety in patients with COVID-19. What is hydroxychloroquine?  Hydroxychloroquine (HCQ) (aka hydroxychloroquine sulfate), is a drug available in the market to tre...

Find More

pharma news
AstraZeneca targets for COVID-19 antibody trial; Arrakis, Roche team up; GSK, AstraZeneca launch testing lab, U.S. government funds OraSure

AstraZeneca aims for summer start for COVID-19 antibody trial AstraZeneca has made its multipronged approach to the development of antibodies against the pandemic SARS-CoV-2 virus. The giant is utilizing its discovery capabilities and assisting in assessing the candidates who were identified in China and the U.S...

Find More

artificial intelligence and covid-19
COVID-19 crisis can prove to be a catalyst for Artificial Intelligence in Healthcare

The novel coronavirus (COVID-19) within a span of five months, has infected around 1 million people, resulting in deaths of 50,000 people in over 180 countries around the world till date.  The major issue right now is containing its rapid transmission and effective treatment option. Apart from these issues,...

Find More

Delveinsight
World Health Day

World Health Day Today, 7 April, is World Health Day. While the world is waging war against COVID-19, let us take a moment to be grateful to the emergency stuff- Doctors, Heath workers, Nurses who are taking care of the patients all day and night during this Coronavirus pandemic crisis.  Everyone is mainta...

Find More

Telemedicine
Telemedicine: Can it be the future of healthcare?

Telemedicine is one of the fastest-growing domains in the healthcare industry. Telemedicine is the practice of providing healthcare services like evaluation, diagnosis and treatment to the patients using telecommunication technology where both the healthcare provider and patient are present at different locations. ...

Find More

COVID-19 Pharma News
J&J’s COVID-19 Vaccine; GigaGen COVID-19 therapy; FDA approved Abbott’s POC test; Cobra Bio raises $ 3.3 M

Johnson & Johnson is fast-forwarding its vaccine development program for COVID-19.  The healthcare company has selected a lead vaccine candidate and is planning to begin human trials in September, with first batches available under potential emergency use authorization in the first part of 2021. The ...

Find More

Dementia is one of the major chronic and progressive syndrome caused by a number of different condit.....

Find More

Systemic Lupus Erythematosus (SLE) is an autoimmune disease where the immune system of the body mist.....

Find More

Over the years, the Oncology domain has experienced the entry of several treatment approaches. Thera.....

Find More

Remdesivir is a broad-spectrum antiviral drug that has previously demonstrated in vitro and in vivo .....

Find More

The Digital Era has officially hit Prime Time. Currently, the potentiality to digitally transform a .....

Find More

Metachromatic Leukodystrophy (MLD) is a rare hereditary disease characterized by the accumulation of.....

Find More